$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the market price of giritinib in China? Drug Pricing and Purchasing Access
2026-02-01 22:25:32
Check Details
How effective is midostaurin in treating AML? Clinical data and patient feedback
2026-02-01 22:25:32
Check Details
Is cabergoline safe to breastfeed? Experts give authoritative answers!
2026-02-01 22:25:32
Check Details
Is molotinib/mometinib a targeted drug? Analysis of mechanism of action and clinical application
2026-02-01 22:25:32
Check Details
How much does Bituvi/Bikonprenol tablets cost after medical insurance reimburses them? Interpretation of the latest prices and policies in 2025
2026-02-01 22:25:32
Check Details
Guanfacine administration methods and dosage
2026-02-01 22:25:32
Check Details
Deuterated colexitinib improves quality of life in patients with moderate to severe psoriasis
2026-02-01 22:25:32
Check Details
A complete inventory of the side effects and efficacy of Apremilast/Apremilast tablets, a must-read before taking the medication!
2026-02-01 22:25:32
Check Details
Valganciclovir (Valganciclovir) Instructions: Correct Taking Method and Dosage Guide
2026-02-01 22:25:32
Check Details
Are generic aprecitentan drugs reliable? Comprehensive comparison of efficacy and safety
2026-02-01 22:25:32
Check Details
What is the correct injection method for tilsiparatide/tilpotide?
2026-02-01 22:25:32
Check Details
Detailed explanation of the functions and efficacy of Guanfacine
2026-02-01 22:25:32
Check Details
1
2
...
1466
1467
1468
1469
1470
1471
1472
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
2
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
3
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
4
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
5
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
6
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
7
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
8
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
9
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
10
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
11
Filgotinib: Mechanism of Action and Clinical Applications Explained
12
Lapatinib: Proper Administration Guide and Key Precautions